BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34652464)

  • 1. [Chronic progressive bone pain in an 82-year-old male patient].
    Brückel J
    Internist (Berl); 2021 Dec; 62(12):1343-1348. PubMed ID: 34652464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
    Ni HJ; Clifton-Bligh R; Brzozowska MM
    Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibroblast Growth Factor 23-Producing Phosphaturic Mesenchymal Tumor with Extraordinary Morphology Causing Oncogenic Osteomalacia.
    Then C; Asbach E; Bartsch H; Thon N; Betz C; Reincke M; Schmidmaier R
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31963334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reports of 17 Chinese patients with tumor-induced osteomalacia.
    Yu WJ; He JW; Fu WZ; Wang C; Zhang ZL
    J Bone Miner Metab; 2017 May; 35(3):298-307. PubMed ID: 27085966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT.
    Clifton-Bligh RJ; Hofman MS; Duncan E; Sim IeW; Darnell D; Clarkson A; Wong T; Walsh JP; Gill AJ; Ebeling PR; Hicks RJ
    J Clin Endocrinol Metab; 2013 Feb; 98(2):687-94. PubMed ID: 23295468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphenoid sinus is a rare site for tumor-induced osteomalacia: A case report and literature review.
    Wang F; He W; Ma D; Xu W; Xie J; Yuan G
    Front Endocrinol (Lausanne); 2023; 14():1116793. PubMed ID: 37033241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report.
    Li J; Huang Y; Yang F; Zhang Q; Chen D; Wang Q
    Medicine (Baltimore); 2018 Dec; 97(52):e13849. PubMed ID: 30593185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
    Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
    Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial Phosphaturic Mesenchymal Tumor Detected by 68 Ga-DOTATATE PET/CT.
    Shi Q; Cheng J; Zhang Y; Su M
    Clin Nucl Med; 2024 May; 49(5):459-461. PubMed ID: 38271243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ga-68 DOTATATE Positron Emission Tomography-Computed Tomography Imaging in Oncogenic Osteomalacia: Experience from a Tertiary Level Hospital in South India.
    John JR; Hephzibah J; Oommen R; Shanthly N; Mathew D
    Indian J Nucl Med; 2019; 34(3):188-193. PubMed ID: 31293296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic osteomalacia due to phosphaturic mesenchymal tumour in the upper thoracic spine.
    Garg B; Mehta N; Goyal A; Khadgawat R
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33328210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor induced osteomalacia: A single center experience on 17 patients.
    Crotti C; Bartoli F; Coletto LA; Manara M; Marini E; Daolio PA; Parafioriti A; Armiraglio E; Zucchi F; Sinigaglia L; Caporali R; Varenna M
    Bone; 2021 Nov; 152():116077. PubMed ID: 34175499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt.
    Seemann L; Padala SA; Mohammed A; Belayneh N
    J Investig Med High Impact Case Rep; 2019; 7():2324709619895162. PubMed ID: 31850815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of recurrent spinal phosphaturic mesenchymal tumor-induced osteomalacia: A case report.
    Liu S; Zhou X; Song A; Huo Z; Wang Y; Liu Y
    Medicine (Baltimore); 2020 Jan; 99(4):e18603. PubMed ID: 31977851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-induced osteomalacia: experience from a South American academic center.
    González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
    Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor-induced osteomalacia: rhinosinusal hemangiopericytoma].
    Serafini EM; Pisarevsky AA; Plumet Garrido J; Zamora RJ; Petrucci EA
    Medicina (B Aires); 2013; 73(1):39-42. PubMed ID: 23335705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.
    Agrawal K; Bhadada S; Mittal BR; Shukla J; Sood A; Bhattacharya A; Bhansali A
    Clin Nucl Med; 2015 Jan; 40(1):e6-e10. PubMed ID: 24999675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
    Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
    BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
    Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
    Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.